Pictet Asset Management Holding SA »

Royalty Pharma shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $18M 605k 30.40

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Royalty Pharma

Morgan Stanley
Vanguard Group
FMR
BlackRock
Baillie Gifford & Co
Viking Global Investors
Adage Capital Partners GP
Jpmorgan Chase & Co
Geode Capital Management
Unisphere Establishment
Millennium Management
Siguler Guff Advisers
Legal & General Group
Northern Trust
Suvretta Capital Management

View all funds holding Royalty Pharma